FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £14.39m
- £14.53m
- £1.97m
Fusion Antibodies - AGM statement and H1 trading update
Fusion Antibodies - Contract win
Fusion Antibodies - Posting of Annual Report & Notice of AGM
Fusion Antibodies - OptiMAL R&D Update
RCS - Fusion Antibodies - Belfast investor presentation
Fusion Antibodies - Final Results
Fusion Antibodies - Contract Win
Brief: Fusion Antibodies Announces Contract Wins With Existing Client
Fusion Antibodies - Contract wins with existing client
RCS - Fusion Antibodies - Investor presentations
Fusion Antibodies - Issue Notification: US Patent Update
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Update on U.S. Patent for OptiMAL®
RCS - Fusion Antibodies - Investor presentation
Fusion Antibodies - Issue of shares to non-executive directors
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Holding(s) in Company
Brief: Fusion Antibodies Unaudited Revenues For FY25 At £1.96M
Fusion Antibodies - Trading update